185 related articles for article (PubMed ID: 15678760)
1. A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy.
Kawaji T; Ando Y; Ando E; Nakamura M; Hirata A; Tanihara H
Amyloid; 2004 Dec; 11(4):257-9. PubMed ID: 15678760
[TBL] [Abstract][Full Text] [Related]
2. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
[TBL] [Abstract][Full Text] [Related]
3. Immunostaining images of vitreous transthyretin amyloid.
Latasiewicz M; Adan A; Solé M
Can J Ophthalmol; 2015 Oct; 50(5):384-7. PubMed ID: 26455975
[TBL] [Abstract][Full Text] [Related]
4. RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS.
Ferreira NN; Cunha Dias DA; Afonso Carvalho RP; Pardal Monteiro Coelho MT
Retin Cases Brief Rep; 2019 Summer; 13(3):273-278. PubMed ID: 28333852
[TBL] [Abstract][Full Text] [Related]
5. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
Ishida K; Nishida T; Niimi Y; Suemori S; Mochizuki K; Kawakami H; Kimura A; Hirayama T
Ophthalmic Genet; 2017; 38(4):387-391. PubMed ID: 28085522
[TBL] [Abstract][Full Text] [Related]
6. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy.
Koga T; Ando E; Hirata A; Fukushima M; Kimura A; Ando Y; Negi A; Tanihara H
Am J Ophthalmol; 2003 Feb; 135(2):188-93. PubMed ID: 12566023
[TBL] [Abstract][Full Text] [Related]
7. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
[TBL] [Abstract][Full Text] [Related]
9. Secondary glaucoma in patients with familial amyloidotic polyneuropathy.
Kimura A; Ando E; Fukushima M; Koga T; Hirata A; Arimura K; Ando Y; Negi A; Tanihara H
Arch Ophthalmol; 2003 Mar; 121(3):351-6. PubMed ID: 12617705
[TBL] [Abstract][Full Text] [Related]
10. Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation.
Ciulla TA; Tolentino F; Morrow JF; Dryja TP
Surv Ophthalmol; 1995; 40(3):197-206. PubMed ID: 8599155
[TBL] [Abstract][Full Text] [Related]
11. Vitreous involvement as initial presentation of hereditary transthyretin amyloidosis related to the rare TTR Ile107Met (p.Ile127Met) pathogenic variant.
Treviño-Herrera AB; Bustamante-Vargas AP; Lisker-Cervantes A; Ríos Y Valles Valles D; Villanueva-Mendoza C; González-Duarte A; Concha-Del-Río LE
Ophthalmic Genet; 2022 Jun; 43(3):413-419. PubMed ID: 35038954
[TBL] [Abstract][Full Text] [Related]
12. [Transthyretin Arg-83 mutation in vitreous amyloidosis].
Chen L; Lü L; Zhang P; Li Y; Lin J
Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962
[TBL] [Abstract][Full Text] [Related]
13. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.
O'Hearn TM; Fawzi A; He S; Rao NA; Lim JI
Br J Ophthalmol; 2007 Dec; 91(12):1607-9. PubMed ID: 17522146
[TBL] [Abstract][Full Text] [Related]
14. A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
Kono S; Manabe Y; Tanaka T; Fujii D; Sakai Y; Narai H; Omori N; Ueda M; Ando Y; Abe K
Intern Med; 2010; 49(12):1213-6. PubMed ID: 20558946
[TBL] [Abstract][Full Text] [Related]
15. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin.
Munar-Qués M; Salva-Ladaria L; Mulet-Perera P; Solé M; López-Andreu FR; Saraiva MJ
Amyloid; 2000 Dec; 7(4):266-9. PubMed ID: 11132095
[TBL] [Abstract][Full Text] [Related]
16. Vitreous surgery impact in glaucoma development in liver transplanted familial amyloidosis ATTR V30M Portuguese patients.
Beirão NM; Matos ME; Meneres MJ; Beirão IM; Costa PP; Torres PA
Amyloid; 2012 Sep; 19(3):146-51. PubMed ID: 22856884
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of vitreous amyloidosis and need of surgical reintervention in Portuguese patients with familial amyloidosis ATTR V30M.
Beirão NM; Matos E; Beirão I; Costa PP; Torres P
Retina; 2011; 31(7):1373-7. PubMed ID: 21358362
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin-related vitreous amyloidosis in different endemic areas.
Kawaji T; Ando Y; Ando E; Sandgren O; Suhr OB; Tanihara H
Amyloid; 2010 Sep; 17(3-4):105-8. PubMed ID: 21077797
[TBL] [Abstract][Full Text] [Related]
20. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy.
Miyahara T; Ohta K; Yamamoto Y; Ueno A; Murata T
J Glaucoma; 2007 Jan; 16(1):169-70. PubMed ID: 17224769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
